Development and validation of a new RP-HPLC Method for the simultaneous estimation of Lamivudine, Doravirine and Tenofovir disoproxil fumarate in combined dosage form

Registration ID: IJNRD_226834

Published ID: IJNRDTH00187

DOI: Click Here to Get

Aneesha Kappen , Satya V

Key Words: Lamivudine, Doravirine, Tenofovir disoproxil fumarate, RP-HPLC, method development, validation.

A new, simple, accurate and specific RP-HPLC method was developed for the simultaneous estimation of the Lamivudine, Doravirine and Tenofovir disoproxil fumarate in combined solid dosage form. The chromatogram was run through Kromasil C18 250x4.6mm, 5 column. Mobile phase containing a buffer and acetonitrile in the ratio of 60:40 v/v was pumped through the column at a flow rate of 1ml/min. Buffer used in this method was 0.1% OPA. Temperature of system was maintained at 30°C. The optimized wavelength for Lamivudine, Doravirine and Tenofovir disoproxil fumarate was 272.0 nm. Retention time of Lamivudine, Doravirine and Tenofovir disoproxil fumarate were found to be 2.314 min, 4.616 min and 3.196 min. % RSD of system precision for Lamivudine, Doravirine and Tenofovir disoproxil fumarate were found to be 1.0, 0.9 and 1.0 respectively. % RSD of method precision for Lamivudine, Doravirine Tenofovir were found to be 0.5, 0.7 and 0.5 respectively. % Recovery was obtained as 99.57%, 99.89% and 99.74% for Lamivudine, Doravirine and Tenofovir disoproxil fumarate respectively. LOD values obtained from regression equations of Lamivudine, Doravirine and Tenofovir disoproxil fumarate were 0.27 ppm, 0.09 ppm and 0.18 ppm, and LOQ values obtained from regression equations of Lamivudine, Doravirine and Tenofovir disoproxil fumarate were 0.82ppm, 0.28 ppm and 0.54ppm respectively. Regression equation of Lamivudine was y = 14959x + 1184, Doravirine was y = 28129x + 2766 and of Tenofovir was y = 17361x + 6030.

Published Paper   E-Certificate

Aneesha Kappen & Satya V (August-2024). Development and validation of a new RP-HPLC Method for the simultaneous estimation of Lamivudine, Doravirine and Tenofovir disoproxil fumarate in combined dosage form . INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(8), 243-312. https://ijnrd.org/papers/IJNRDTH00187.pdf

Volume 9 Issue 8, August-2024

Pages : 243-312

Paper Reg. ID: IJNRD_226834

Published Paper Id: IJNRDTH00187

Downloads: 000121983

Research Area: Pharmacy

Country: Kasaragod DT, Kerala , India

Published Paper PDF: https://ijnrd.org/papers/IJNRDTH00187.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRDTH00187

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details